Value Evidence Generation

The quality of the evidence generated to support the value assessment of new medicines is coming under greater scrutiny by Payer organizations around the world, requiring significant attention in the planning and execution of evidence generation. Because GalbraithWight are experts in market access, we help you determine the optimal evidence development plan, and then we develop that evidence to the highest possible standards, so it withstands that scrutiny by the most demanding HTA agencies. From economic models, systematic literature reviews to real-world evidence, we deliver the evidence required, and help you publish it in peer-reviewed settings so it supports the value of our Clients’ brands.


Why Partner with GalbraithWight

  • The global Strategic Market Access Consultancy with 20 years thought leadership partnering Pharma and Biotech Clients.
  • Experts in value strategy based on in-depth customer insights, creating value through clinical and HEOR evidence, achieving successful pricing, reimbursement and funding approval, brand launch and commercialisation, from discovery to loss of exclusivity.
  • Unparalleled expertise in building market access and commercial capabilities from foundation to expert level for global, regional and country teams, training thousands of managers from over 70 countries across 5 continents.
  • Highly expert team with extensive senior level strategic and operational international experience in major Pharma companies, who know and understand how to embed and operationalise our solutions in complex organisations and cross-functional teams, delivered on the ground throughout North and South America, Europe, Asia, Middle East and Africa.

What Our Clients Say

  • The training days were dynamic, energetic and fun to be a part of, and most of all productive in increasing our capability in this area.

    Associate Director – Market AccessSanofi Pasteur MSD
  • For Payer strategy, positioning with payers, market landscape research, value story creation and message testing, absolutely would recommend.

    Senior DirectorAstraZeneca
  • Overall training that changes behaviour. Gold standard. I can truly and honestly recommend all concerned as professional, trustworthy and highly skilled.

    Head of DermatologyGSK